Verfahren zur Behandlung von Krebs mit einem Antikörper-Wirkstoff-Konjugat
EP4799648
1. Mai 2025
Anmelder: Shanghai Hansoh Biomedical Company Limited, Changzhou Hansoh Pharmaceutical Company Limited 🇨🇳
Details
- Veröffentlichungs-Nr.
- EP4799648
- Anmeldetag
- 25. Oktober 2024
- Veröffentlichung
- 1. Mai 2025
- Rechtsraum
- EP
Abstract
The present invention relates to a method for treating a cancer using an antibody-drug conjugate. Specifically, the present invention provides a method for treating a cancer using an antibody-drug conjugate, a pharmaceutically acceptable salt thereof, a stereoisomer thereof, or a metabolite thereof, or a solvate of any one of the foregoing, and use of the antibody-drug conjugate in preparing a medicament for preventing and/or treating a cancer. The method features improved safety and prospective anti-tumor activity in a number of tumors, thus satisfying medical requirements.
Anmelder
- Firmen
- Shanghai Hansoh Biomedical Company Limited
Changzhou Hansoh Pharmaceutical Company Limited - Land
- 🇨🇳 China
Vertreten von
Hanby, Abigail Rose
London, Großbritannien
5
Patente gesamt
2
Fachgebiete
1
Anmelder-Länder
Schwerpunkte